The mRNA and protein levels of RKIP are reduced and those of YY1 increased in clinical HCC. Loss, mutation, or promoter hypermethylation of the RKIP gene may not account for the downregulation of RKIP in HCC. Histone deacetylation can silence gene expression and play a significant role in hepatocarcinogenesis. The histone deacetylase inhibitor (HDACI) trichostatin induced cell growth inhibition and proapoptotic effects in HA22T/VGH and HepG2 HCC cells; it also exhibited synergy with doxorubicin. Treatment with trichostatin caused histone hyperacetylation and down- or upregulated expression of different genes (such as β-catenin, cyclin D1, hTERT, XIAP, and IL-6). These changes might, at least in part, explain the anticancer and chemosensitizing activities of trichostatin. Nevertheless, trichostatin did not modify RKIP or YY1 mRNA and protein levels in the two representative HCC cell lines. Although further studies are necessary to clarify the possible role of epigenetic changes in the expression of RKIP and YY1, our results underline the therapeutic potential of HDACIs in HCC
|Numero di pagine||9|
|Rivista||FORUM ON IMMUNOPATHOLOGICAL DISEASES AND THERAPEUTICS|
|Stato di pubblicazione||Published - 2011|
All Science Journal Classification (ASJC) codes
- Molecular Medicine
Notarbartolo Di Villarosa, M., D'Alessandro, N., Poma, P., Labbozzetta, M., & Inguglia, L. (2011). Induction of Apoptosis and Chemosensitization by the Histone Deacetylase Inhibitor Trichostatin in Hepatocellular Carcinoma Cells: Molecular Analysis and RKIP Levels. FORUM ON IMMUNOPATHOLOGICAL DISEASES AND THERAPEUTICS, 2, 127-135.